You are here: Industry Insights > COVID-19

News List

Small Study Shows Convalescent Plasma Safe in COVID-19 Pediatric Patients americanpharmaceuticalreview
September 24, 2020
Early findings from researchers at Children's Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19.
Celularity Doses First Patient in Trial Evaluating CYNK-001 in COVID-19 Patients americanpharmaceuticalreview
September 24, 2020
Celularity announced the first patient was dosed in a Phase I/II study of human placental hematopoietic stem cell derived NK cells (CYNK-001) for the treatment of adults with COVID-19 as part of a national clinical trial.
CDC: Nearly 800 U.S. Children Have Developed COVID-19-Related Condition drugs.com
September 24, 2020
There have been 792 confirmed cases in the United States of a rare condition in children that is linked to COVID-19, the U.S. Centers for Disease Control and Prevention said Wednesday.
How One Hospital Kept COVID Transmissions at Nearly Zero drugs.com
September 24, 2020
Infection control measures implemented in response to the coronavirus pandemic kept transmission of the virus to patients within a Boston hospital at nearly zero, according to a new study.
Study Confirms Restaurants, Bars Are COVID Infection Hotspots drugs.com
September 24, 2020
Relaxation of face mask requirements in restaurants, coffee shops and bars could make those venues prime areas for transmission of the new coronavirus, research shows.
GigaGen Initiates Large-Scale Manufacturing of GIGA-2050 contractpharma
September 24, 2020
?GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, has initiated large-scale manufacturing of its recombinant hyperimmune drug for COVID-19 ...
Johnson & Johnson Announces that Janssen’s COVID-19 Investigational Vaccine Candidate Prevents Severe Clinical Disease in Pre-clinical Studies drugs.com
September 24, 2020
?Janssen’s lead SARS-CoV-2 investigational vaccine candidate, Ad26.COV2.S, prevented severe clinical disease in Syrian golden hamsters, upon challenge with SARS-CoV-2, the virus that causes COVID-19 in people.
Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU contractpharma
September 24, 2020
Could supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2.
Vela Diagnostics' SARS-CoV-2 RT-PCR Test v2.0 Authorized for Emergency Use in the U.S. prnasia
September 23, 2020
Vela Diagnostics announced today that the ViroKey? SARS-CoV-2 RT-PCR Test v2.0 has obtained the Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA).
IND granted to Ampion as COVID-19 treatment after Phase I study europeanpharmaceuticalreview
September 23, 2020
The FDA has given the green light to an IND and further Phase I clinical trial of Ampio Pharmaceuticals’ Ampion as an inhaled COVID-19 therapy.